July 31 (SeeNews) - Bulgarian pharmaceuticals maker Sopharma [BUL:SFA] said its standalone net profit dropped to 22.3 million levs ($12.3 million/11.4 million euro) in the first half of 2024 from 36.3 million levs a year earlier.